Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present new data highlighting its growing respiratory portfolio and pipeline at European Respiratory Society 2016
-
AstraZeneca to sell small molecule antibiotics business to Pfizer
-
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer’s disease
-
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
-
H1 2016 Results
-
AstraZeneca files first clinical trial application in Moderna messenger RNA collaboration
-
AstraZeneca’s antibiotic Zavicefta met primary endpoints in Phase III trial for treatment of hospital-acquired pneumonia
-
AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of Type 2 diabetes
-
Tagrisso met primary endpoint in phase III 2nd-line lung cancer trial
-
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
Latest articles and press releases
All of our latest press releases and articles are available to explore
